GBM tissue samples (GBM1211, GBM2021) were prospectively acquired and anatomically microdissected into center (C) and margin (M) or peripheral regions followed by immunostaining for TF, TfR1, DRD5, TH, PAH, and DDC. The gene discussed is DRD5; the disease is glioblastoma.